Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (12)
Eva Lundström, Peter Conner, Sabine Naessén, Lars Löfgren, Kjell Carlström & Gunnar Söderqvist. (2015) Estrone – a partial estradiol antagonist in the normal breast. Gynecological Endocrinology 31:9, pages 747-749.
Read now
Read now
P. Stute, H.-G. Becker, J. Bitzer, D. Chatsiproios, F. Luzuy, M. von Wolff, D. Wunder & M. Birkhäuser. (2015) Ultra-low dose – new approaches in menopausal hormone therapy. Climacteric 18:2, pages 182-186.
Read now
Read now
D. W. Sturdee. (2013) Are progestins really necessary as part of a combined HRT regimen?. Climacteric 16:sup1, pages 79-84.
Read now
Read now
H. Zang, H. Shi & L. Speroff. (2010) Low-dose hormone therapy in postmenopausal women in China. Climacteric 13:6, pages 544-552.
Read now
Read now
G. Samsioe & J. Hruska. (2010) Optimal tolerability of ultra-low-dose continuous combined 17β-estradiol and norethisterone acetate: laboratory and safety results. Climacteric 13:1, pages 34-44.
Read now
Read now
A. Stuedal, H. Ma, H. Bjørndal & G. Ursin. (2009) Postmenopausal hormone therapy with estradiol and norethisterone acetate and mammographic density: findings from a cross-sectional study among Norwegian women. Climacteric 12:3, pages 248-258.
Read now
Read now
P. Villa, F. Sagnella, C. Perri, R. Suriano, B. Costantini, F. Macrì, L. Ricciardi & A. Lanzone. (2008) Low- and standard-estrogen dosage in oral therapy: dose-dependent effects on insulin and lipid metabolism in healthy postmenopausal women. Climacteric 11:6, pages 498-508.
Read now
Read now
A. Pines, D. W. Sturdee, M. H. Birkhäuser, T. de Villiers, F. Naftolin, A. Gompel, R. Farmer, D. Barlow, D. Tan, P. Maki, R. Lobo, H. Hodis & et al. on behalf of the International Menopause Society. (2008) HRT in the early menopause: scientific evidence and common perceptions. Climacteric 11:4, pages 267-272.
Read now
Read now
Nick Panay & Anna Fenton. (2008) HRT: does the dose matter?. Climacteric 11:3, pages 177-178.
Read now
Read now
M. H. Birkhäuser, M. H. Birkhäuser, N. Panay, D. F. Archer, D. Barlow, H. Burger, M. Gambacciani, S. Goldstein, J. A. Pinkerton & D. W. Sturdee. (2008) Updated practical recommendations for hormone replacement therapy in the peri- and postmenopause. Climacteric 11:2, pages 108-123.
Read now
Read now
N. Panay. (2007) New products and regimens (since 2003). Climacteric 10:sup2, pages 109-114.
Read now
Read now
D. W. Sturdee. (2007) Endometrial safety and bleeding with HRT: what's new?. Climacteric 10:sup2, pages 66-70.
Read now
Read now
Articles from other publishers (13)
Eva Lundström, Ivana Virijevic & Gunnar Söderqvist. (2020) Progestogen addition with low-dose levonorgestrel intrauterine system in menopausal hormone treatment gives less normal breast tissue proliferation than oral norethisterone acetate or medroxyprogesterone acetate. Hormone Molecular Biology and Clinical Investigation 41:3.
Crossref
Crossref
Angelica Lindén Hirschberg, Edneia Tani, Kerstin Brismar & Eva Lundström. (2019) Effects of drospirenone and norethisterone acetate combined with estradiol on mammographic density and proliferation of breast epithelial cells—A prospective randomized trial. Maturitas 126, pages 18-24.
Crossref
Crossref
Nick Panay. 2018. Dewhurst's Textbook of Obstetrics & Gynaecology. Dewhurst's Textbook of Obstetrics & Gynaecology
672
688
.
Frank Z. StanczykJanet P. Hapgood, Sharon Winer & Daniel R. MishellJr.Jr.. (2013) Progestogens Used in Postmenopausal Hormone Therapy: Differences in Their Pharmacological Properties, Intracellular Actions, and Clinical Effects. Endocrine Reviews 34:2, pages 171-208.
Crossref
Crossref
Nick Panay. 2012. Dewhurst's Textbook of Obstetrics & Gynaecology. Dewhurst's Textbook of Obstetrics & Gynaecology
553
564
.
E. Lundström, A.L. Hirschberg & G. Söderqvist. (2011) Digitized assessment of mammographic breast density – Effects of continuous combined hormone therapy, tibolone and black cohosh compared to placebo. Maturitas 70:4, pages 361-364.
Crossref
Crossref
I. Wiegratz. (2011) Ultraniedrig dosierte HormonersatztherapieUltralow-dose hormone replacement therapy. Gynäkologische Endokrinologie 9:3, pages 165-170.
Crossref
Crossref
Leon Speroff. (2010) A tender subject. Menopause 17:3, pages 445-449.
Crossref
Crossref
Gunnar Söderqvist. (2010) Mechanisms for differential effects between natural progesterone and synthetic progestogens on normal breast tissue. Hormone Molecular Biology and Clinical Investigation 3:3.
Crossref
Crossref
S Daayana & C M Holland. (2009) Hormone replacement therapy and the endometrium. Menopause International 15:3, pages 134-138.
Crossref
Crossref
PETER CONNER, EVA LUNDSTRÖM & BO VON SCHOULTZ. (2008) Breast Cancer and Hormonal Therapy. Clinical Obstetrics & Gynecology 51:3, pages 592-606.
Crossref
Crossref
Odd Erik Johansen & Erik Qvigstad. (2008) Rationale for low-dose systemic hormone replacement therapy and review of estradiol 0.5 mg/NETA 0.1 mg. Advances in Therapy 25:6, pages 525-551.
Crossref
Crossref
L.P. Shulman. (2008) Neutral effect of ultra-low-dose continuous combined estradiol and norethisterone acetate on mammographic breast density. Yearbook of Obstetrics, Gynecology and Women's Health 2008, pages 286.
Crossref
Crossref